AR and posterior cortical atrophy: The combination of ADT and docetaxel in patients with newly diagnosed, high-risk, clinically localized PCa in the neoadjuvant setting is associated with upregulation of both AR and AR-V expression as well as a subset of neuroendocrine and plasticity genes (65).